Condensed Consolidated Balance Sheets - USD ($)	Sep. 30, 2026	Dec. 31, 2025
Current Assets:
Cash and cash equivalents	$ 430,333	$ 459,174
Prepaid expenses and other current assets	657,307	159,985
Total Current Assets	1,087,640	619,159
Total Assets	1,087,640	619,159
Current Liabilities:
Accounts payable - trade	1,688,926	1,512,090
Accrued expenses	990,185	596,465
Financing liability	81,987
Total Current Liabilities	2,761,098	2,108,555
Total Liabilities	2,761,098	2,108,555
Commitments and contingencies (Note 12)
Stockholders’ Deficit:
Preferred stock, $0.0001 par value, 10,000,000 shares authorized, 0 shares issued and outstanding as of September 30, 2026 and December 31, 2025
Common stock, $0.0001 par value; 50,000,000 shares authorized; 9,261,601 and 8,655,829 shares issued and outstanding as of September 30, 2026 and December 31, 2025, respectively	926	866
Additional paid-in capital	10,926,166	7,801,539
Accumulated deficit	(12,600,550)	(9,291,801)
Total Stockholders’ Deficit	(1,673,458)	(1,489,396)
Total Liabilities and Stockholders’ Deficit	$ 1,087,640	$ 619,159

Amount of Financing liability.

No definition available.

Name:	ck0001938571_FinancingLiabilityCurrent
Namespace Prefix:	ck0001938571_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).